These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 15492846

  • 21. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation.
    Lal B, Xia S, Abounader R, Laterra J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4479-86. PubMed ID: 15958633
    [Abstract] [Full Text] [Related]

  • 22. Enhancement of pleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs).
    Ishii H, Yazawa T, Sato H, Suzuki T, Ikeda M, Hayashi Y, Takanashi Y, Kitamura H.
    Lung Cancer; 2004 Sep 15; 45(3):325-37. PubMed ID: 15301873
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 24. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
    Worden B, Yang XP, Lee TL, Bagain L, Yeh NT, Cohen JG, Van Waes C, Chen Z.
    Cancer Res; 2005 Aug 15; 65(16):7071-80. PubMed ID: 16103054
    [Abstract] [Full Text] [Related]

  • 25. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.
    Qian CN, Guo X, Cao B, Kort EJ, Lee CC, Chen J, Wang LM, Mai WY, Min HQ, Hong MH, Vande Woude GF, Resau JH, Teh BT.
    Cancer Res; 2002 Jan 15; 62(2):589-96. PubMed ID: 11809714
    [Abstract] [Full Text] [Related]

  • 26. Hepatocyte growth factor and c-Met expression in rat and human liver fibrosis.
    Cramer T, Schuppan D, Bauer M, Pfander D, Neuhaus P, Herbst H.
    Liver Int; 2004 Aug 15; 24(4):335-44. PubMed ID: 15287857
    [Abstract] [Full Text] [Related]

  • 27. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.
    Harvey P, Warn A, Newman P, Perry LJ, Ball RY, Warn RM.
    J Pathol; 1996 Dec 15; 180(4):389-94. PubMed ID: 9014859
    [Abstract] [Full Text] [Related]

  • 28. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.
    Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini P, Cremona O, Campanacci M, Comoglio PM.
    Oncogene; 1995 Feb 16; 10(4):739-49. PubMed ID: 7862451
    [Abstract] [Full Text] [Related]

  • 29. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.
    Nakashiro K, Hayashi Y, Oyasu R.
    Oncol Rep; 2003 Feb 16; 10(5):1149-53. PubMed ID: 12883672
    [Abstract] [Full Text] [Related]

  • 30. Autocrine and/or paracrine growth of aggressive ATLL cells caused by HGF and c-Met.
    Onimaru Y, Tsukasaki K, Murata K, Imaizumi Y, Choi YL, Hasegawa H, Sugahara K, Yamada Y, Hayashi T, Nakashima M, Taguchi T, Mano H, Kamihira S, Tomonaga M.
    Int J Oncol; 2008 Oct 16; 33(4):697-703. PubMed ID: 18813782
    [Abstract] [Full Text] [Related]

  • 31. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
    Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476
    [Abstract] [Full Text] [Related]

  • 32. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro.
    Su W, Gutmann DH, Perry A, Abounader R, Laterra J, Sherman LS.
    Glia; 2004 Feb 15; 45(3):297-306. PubMed ID: 14730703
    [Abstract] [Full Text] [Related]

  • 33. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
    Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B.
    Breast Cancer Res Treat; 2005 Nov 15; 94(1):71-80. PubMed ID: 16142438
    [Abstract] [Full Text] [Related]

  • 34. Expression of the met-receptor and its ligand, HGF-SF during mouse embryogenesis.
    Sonnenberg E, Weidner KM, Birchmeier C.
    EXS; 1993 Nov 15; 65():381-94. PubMed ID: 8380744
    [Abstract] [Full Text] [Related]

  • 35. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K, Nakamura T, Sakai K, Nakamura T.
    Proteomics; 2008 Aug 15; 8(16):3360-70. PubMed ID: 18646008
    [Abstract] [Full Text] [Related]

  • 36. Hepatocyte growth factor/scatter factor induces VEGF in human external auditory canal cholesteatoma cell culture.
    Naim R, Sadick H, Bayerl C, Riedel F, Schafer C, Bran G, Hormann K.
    Int J Mol Med; 2005 Jan 15; 15(1):67-71. PubMed ID: 15583829
    [Abstract] [Full Text] [Related]

  • 37. A novel one-armed anti-c-Met antibody inhibits glioblastoma growth in vivo.
    Martens T, Schmidt NO, Eckerich C, Fillbrandt R, Merchant M, Schwall R, Westphal M, Lamszus K.
    Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6144-52. PubMed ID: 17062691
    [Abstract] [Full Text] [Related]

  • 38. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats.
    Shimamura M, Sato N, Sata M, Wakayama K, Ogihara T, Morishita R.
    Brain Res; 2007 Jun 02; 1151():188-94. PubMed ID: 17425951
    [Abstract] [Full Text] [Related]

  • 39. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
    Otsuka T, Takayama H, Sharp R, Celli G, LaRochelle WJ, Bottaro DP, Ellmore N, Vieira W, Owens JW, Anver M, Merlino G.
    Cancer Res; 1998 Nov 15; 58(22):5157-67. PubMed ID: 9823327
    [Abstract] [Full Text] [Related]

  • 40. Expression and functional role of hepatocyte growth factor and its receptor (c-met) during fetal mouse testis development.
    Ricci G, Catizone A, Galdieri M.
    J Endocrinol; 2006 Dec 15; 191(3):559-70. PubMed ID: 17170214
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.